An Act preserving access to treatment for patients with serious mental illnesses
This bill defines "serious mental illness" using the DSM criteria (including conditions like schizophrenia, bipolar disorder, and PTSD) to clarify which patients qualify for protections. It prohibits health insurers and state health programs from requiring prior authorization, step therapy, or other delays for FDA-approved medications treating these conditions. The law directly affects patients with qualifying mental health conditions by removing insurance barriers to accessing necessary medications. It applies to both private insurance plans and state-managed health programs under Massachusetts law.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 8, 2026
Last action Aug 4, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
5
Key actions
2
Committee
3
Aug 4, 2026
Committee
Committee recommended bill ought to pass and referred to the committee on House Ways and Means
lower
Jan 8, 2026
Lower · Passed
Reported favorably by committee and referred to the committee on Health Care Financing
lower
Jan 8, 2026
Lower · Passed
Reported from the committee on Financial Services
lower
0 primary · 13 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about H 4892
Scope: MA
Hi! I can help you understand H 4892. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline